What is Immunotherapy?

In immunotherapy, the patient’s immune system is activated to fight cancer. This means that the patient’s own immune system is trained and boosted through genetic modifications to recognise and attack malignant cancer cells, which before could go unnoticed by our immune system.

At DTU Health Tech, we strive to get a better understanding of the human immune system. This knowledge will allow us to create better treatments such as improved immunotherapy. We are occupied with very basic research e.g. on the workings of the immune system and its many parts. We are also working within areas much closer to the clinic with the development of CAR T-cell therapy as an example.

EliteForsk awardee 2020: Professor Sine Reker Hadrup. (In Danish)
Illustration of the combined specificity tree for HLA-DR, HLA-DP, and HLA-DQ. Orange molecules have peptide coverage corresponding to at least 50 high-confidence ligands, and blue molecules have a pseudo-sequence distance of at most 0.05 to an orange molecule. Logos in red frames correspond to noncovered molecules. Credit: Jonas Birkelund Nilsson.
T cells are a special type of white blood cell found in our immune system. The image is a colorized scanning electron micrograph of aT cell from NIAID.

Contact for more info

To learn more about this topic, contact these researchers

Sine Reker Hadrup

Sine Reker Hadrup Head of Section, Professor Department of Health Technology Phone: +45 35886290 Mobile: +45 27125221

Morten Nielsen

Morten Nielsen Groupleader, Professor Department of Health Technology Phone: +45 45252425

Jonas Rosager Henriksen

Jonas Rosager Henriksen Head of Section, Associate Professor Department of Health Technology Mobile: +45 40582866